Glucagon-like peptide-1 analogues for overweight or obese adults
No hay miniatura disponible
Fecha
2022-09-08
Profesor/a Guía
Facultad/escuela
Idioma
en
Título de la revista
ISSN de la revista
Título del volumen
Editor
John Wiley and Sons Ltd
Nombre de Curso
Licencia CC
CC BY 4.0 DEED
Atribución 4.0 Internacional
Licencia CC
https://creativecommons.org/licenses/by/4.0/deed.es
Resumen
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of glucagon-like peptide-1 analogues on overweight or obese adults. Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Notas
Indexación: Scopus.
Palabras clave
Glucagon like peptide 1, Hemoglobin A1c, Abdominal discomfort, Adult, Article, Body mass, Cardiovascular risk, Cerebrovascular accident, Constipation, Diarrhea, Dyslipidemia, Dyspepsia, Energy expenditure, Follow up, Food intake, Human, Hypertension, Nausea, Non insulin dependent diabetes mellitus, Obesity, Outcome assessment, Physical activity, Prevalence, Quality of life, Randomized controlled trial (topic), Risk assessment, Risk factor, Sensitivity analysis, Sleep disordered breathing, Vomiting
Citación
Cochrane Database of Systematic Reviews, Volume 2022, Issue 9, 8 September 2022, Article number CD015092
DOI
10.1002/14651858.CD015092